Breaking News Instant updates and real-time market news.

DTIL

Precision BioSciences

$13.29 /

-0.28 (-2.06%)

07:07
01/25/21
01/25
07:07
01/25/21
07:07

Precision BioSciences granted patent for candidate for Non-Hodgkin Lymphoma

Precision BioSciences has received a Notice of Allowance from the USPTO for a patent application covering PBCAR19B, a next-generation, stealth cell, CD19 product candidate for patients with relapsed/refractory Non-Hodgkin Lymphoma. The allowed composition claims of the patent application encompass genetically-modified human T cells comprising the company's PBCAR19B construct, which is inserted within the T cell receptor alpha constant locus. Once issued, patents arising from this patent family will have standard expiration dates in April 2040.

DTIL Precision BioSciences
$13.29 /

-0.28 (-2.06%)

12/15/20 H.C. Wainwright
Precision BioSciences transferred with Buy rating at H.C. Wainwright
12/04/20 Stifel
Precision's PBCAR0191 durability 'a disappointment,' says Stifel
12/04/20 BTIG
Precision BioSciences data provide clear path forward, says BTIG
11/20/20 Stifel
Precision BioSciences price target raised to $22 from $21 at Stifel

TODAY'S FREE FLY STORIES

Recommendations
Stephens says Wendy's remains a 2021 Best Idea after 'beat and raise' report » 16:13
05/12/21
05/12
16:13
05/12/21
16:13
WEN

Wendy's

$22.50 /

-0.3 (-1.32%)

Stephens analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WEN Wendy's
$22.50 /

-0.3 (-1.32%)

WEN Wendy's
$22.50 /

-0.3 (-1.32%)

14:45 Today Wedbush
Wedbush ups Wendy's price target to $28.50 following quarterly results
04/12/21 JPMorgan
Wendy's price target raised to $27 from $25 at JPMorgan
03/24/21 Wedbush
Wendy's added to Best Ideas List at Wedbush
03/22/21
Fly Intel: Top five analyst downgrades
WEN Wendy's
$22.50 /

-0.3 (-1.32%)

WEN Wendy's
$22.50 /

-0.3 (-1.32%)

WEN Wendy's
$22.50 /

-0.3 (-1.32%)

WEN Wendy's
$22.50 /

-0.3 (-1.32%)

Earnings
Acutus Medical reports Q1 EPS 97c, consensus (81c) » 16:13
05/12/21
05/12
16:13
05/12/21
16:13
AFIB

Acutus Medical

$11.60 /

-0.33 (-2.77%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

03/19/21 Canaccord
Acutus Medical price target lowered to $16 from $30 at Canaccord
03/19/21 William Blair
Acutus Medical downgraded to Market Perform from Outperform at William Blair
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral with $19 target at JPMorgan
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral from Overweight at JPMorgan
AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

  • 06
    Aug
AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

Earnings
Amwell reports Q1 EPS (16c), consensus (19c) » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
AMWL

Amwell

$12.87 /

+0.17 (+1.34%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

AMWL Amwell
$12.87 /

+0.17 (+1.34%)

05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
04/26/21 Piper Sandler
Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
04/16/21 KeyBanc
Amwell initiated with a Sector Weight at KeyBanc
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

  • 15
    Jan
  • 17
    Sep
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

AMWL Amwell
$12.87 /

+0.17 (+1.34%)

Earnings
Compass sees Q2 revenue $1.5B-$1.6B, consensus $1.27B » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
COMP

Compass

$14.25 /

-1.14 (-7.41%)

Sees Q2 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COMP Compass
$14.25 /

-1.14 (-7.41%)

COMP Compass
$14.25 /

-1.14 (-7.41%)

04/26/21
Fly Intel: Top five analyst initiations
04/26/21 Morgan Stanley
Compass initiated with an Overweight at Morgan Stanley
04/26/21 Oppenheimer
Compass initiated with an Outperform at Oppenheimer
04/26/21 Loop Capital
Compass initiated with a Hold at Loop Capital
COMP Compass
$14.25 /

-1.14 (-7.41%)

  • 01
    Apr
COMP Compass
$14.25 /

-1.14 (-7.41%)

COMP Compass
$14.25 /

-1.14 (-7.41%)

COMP Compass
$14.25 /

-1.14 (-7.41%)

Hot Stocks
Boot Barn sees FY22 new unit growth of 10% » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
BOOT

Boot Barn

$67.43 /

-5.03 (-6.94%)

The company is not…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

02/10/21 Cowen
Boot Barn price target raised to $68 from $65 at Cowen
01/26/21 Jefferies
Boot Barn price target raised to $72 from $68 at Jefferies
01/26/21 Craig-Hallum
Boot Barn price target raised to $54 from $48 at Craig-Hallum
01/26/21 William Blair
Boot Barn valuation remains 'compelling,' says William Blair
BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

Earnings
Relmada Therapeutics reports Q1 EPS ($1.34), consensus ($1.39) » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
RLMD

Relmada Therapeutics

$33.70 /

-1.32 (-3.77%)

"We continue to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RLMD Relmada Therapeutics
$33.70 /

-1.32 (-3.77%)

RLMD Relmada Therapeutics
$33.70 /

-1.32 (-3.77%)

10/28/20 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
05/27/20 Goldman Sachs
Goldman says Relmada clearance for Phase 3 supports REL-1017 safety, efficacy
RLMD Relmada Therapeutics
$33.70 /

-1.32 (-3.77%)

Hot Stocks
ContextLogic names Jacqueline Reses executive chair » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
WISH

ContextLogic

$11.43 /

-0.315 (-2.68%)

ContextLogic announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WISH ContextLogic
$11.43 /

-0.315 (-2.68%)

WISH ContextLogic
$11.43 /

-0.315 (-2.68%)

04/05/21 Evercore ISI
ContextLogic initiated with an Outperform at Evercore ISI
03/30/21 Loop Capital
ContextLogic to 'lap' easy comparisons in Q1, says Loop Capital
03/18/21 JPMorgan
ContextLogic shares attractive at current levels, says JPMorgan
03/09/21 Stifel
ContextLogic price target lowered to $20 from $22 at Stifel
WISH ContextLogic
$11.43 /

-0.315 (-2.68%)

  • 16
    Dec
WISH ContextLogic
$11.43 /

-0.315 (-2.68%)

WISH ContextLogic
$11.43 /

-0.315 (-2.68%)

WISH ContextLogic
$11.43 /

-0.315 (-2.68%)

Earnings
NV5 Global sees FY21 adjusted EPS $4.05-$4.45, consensus $4.00 » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
NVEE

NV5 Global

$81.45 /

-4.55 (-5.29%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVEE NV5 Global
$81.45 /

-4.55 (-5.29%)

NVEE NV5 Global
$81.45 /

-4.55 (-5.29%)

03/29/21 Roth Capital
Roth Capital positive on NV5 acquisition of Geodynamics
03/15/21 Baird
NV5 Global initiated with an Outperform at Baird
01/13/21 Roth Capital
NV5 Global price target raised to $136 from $82 at Roth Capital
11/12/20 Roth Capital
NV5 Global price target raised to $82 from $77 at Roth Capital
NVEE NV5 Global
$81.45 /

-4.55 (-5.29%)

  • 11
    Mar
NVEE NV5 Global
$81.45 /

-4.55 (-5.29%)

Earnings
Boot Barn reports Q4 EPS ex-tax benefit 75c, consensus 47c » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
BOOT

Boot Barn

$67.43 /

-5.03 (-6.94%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

02/10/21 Cowen
Boot Barn price target raised to $68 from $65 at Cowen
01/26/21 Jefferies
Boot Barn price target raised to $72 from $68 at Jefferies
01/26/21 Craig-Hallum
Boot Barn price target raised to $54 from $48 at Craig-Hallum
01/26/21 William Blair
Boot Barn valuation remains 'compelling,' says William Blair
BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

Earnings
ContextLogic sees Q2 revenue $715M-$730M, consensus $759.13M » 16:11
05/12/21
05/12
16:11
05/12/21
16:11
WISH

ContextLogic

$11.45 /

-0.295 (-2.51%)

Sees Q2 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WISH ContextLogic
$11.45 /

-0.295 (-2.51%)

WISH ContextLogic
$11.45 /

-0.295 (-2.51%)

04/05/21 Evercore ISI
ContextLogic initiated with an Outperform at Evercore ISI
03/30/21 Loop Capital
ContextLogic to 'lap' easy comparisons in Q1, says Loop Capital
03/18/21 JPMorgan
ContextLogic shares attractive at current levels, says JPMorgan
03/09/21 Stifel
ContextLogic price target lowered to $20 from $22 at Stifel
WISH ContextLogic
$11.45 /

-0.295 (-2.51%)

  • 16
    Dec
WISH ContextLogic
$11.45 /

-0.295 (-2.51%)

WISH ContextLogic
$11.45 /

-0.295 (-2.51%)

WISH ContextLogic
$11.45 /

-0.295 (-2.51%)

Earnings
Compass reports Q1 EPS ($1.67), consensus (25c) » 16:11
05/12/21
05/12
16:11
05/12/21
16:11
COMP

Compass

$14.34 /

-1.05 (-6.82%)

Reports Q1 revenue $1.1B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COMP Compass
$14.34 /

-1.05 (-6.82%)

COMP Compass
$14.34 /

-1.05 (-6.82%)

04/26/21
Fly Intel: Top five analyst initiations
04/26/21 Morgan Stanley
Compass initiated with an Overweight at Morgan Stanley
04/26/21 Oppenheimer
Compass initiated with an Outperform at Oppenheimer
04/26/21 Loop Capital
Compass initiated with a Hold at Loop Capital
  • 01
    Apr
COMP Compass
$14.34 /

-1.05 (-6.82%)

COMP Compass
$14.34 /

-1.05 (-6.82%)

COMP Compass
$14.34 /

-1.05 (-6.82%)

Hot Stocks
Vroom sees triple digit y/y growth in ecommerce unit sales for FY21  16:11
05/12/21
05/12
16:11
05/12/21
16:11
VRM

Vroom

$35.40 /

-1.44 (-3.91%)

 
ShowHide Related Items >><<
VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
04/07/21 Raymond James
Raymond James starts Vroom at Outperform on digital auto secular growth
04/07/21 Raymond James
Vroom initiated with an Outperform at Raymond James
03/04/21 Truist
Vroom price target lowered to $54 from $58 at Truist
VRM Vroom
$35.40 /

-1.44 (-3.91%)

  • 07
    Dec
  • 11
    Sep
  • 09
    Jun
VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

Upgrade
Array Technologies upgraded to Outperform at Credit Suisse following pullback » 16:11
05/12/21
05/12
16:11
05/12/21
16:11
ARRY

Array Technologies

$13.42 /

-11.54 (-46.23%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARRY Array Technologies
$13.42 /

-11.54 (-46.23%)

ARRY Array Technologies
$13.42 /

-11.54 (-46.23%)

16:10 Today Credit Suisse
Array Technologies upgraded to Outperform at Credit Suisse following pullback
16:06 Today Credit Suisse
Array Technologies upgraded to Outperform from Neutral at Credit Suisse
06:07 Today Piper Sandler
Array Technologies downgraded to Neutral from Overweight at Piper Sandler
05:57 Today Barclays
Array Technologies downgraded to Underweight from Overweight at Barclays
ARRY Array Technologies
$13.42 /

-11.54 (-46.23%)

  • 19
    Mar
  • 03
    Dec
  • 15
    Oct
ARRY Array Technologies
$13.42 /

-11.54 (-46.23%)

Earnings
Vroom sees Q2 EPS (58c)-(51c), cosnensus (44c) » 16:11
05/12/21
05/12
16:11
05/12/21
16:11
VRM

Vroom

$35.40 /

-1.44 (-3.91%)

Sees Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
04/07/21 Raymond James
Raymond James starts Vroom at Outperform on digital auto secular growth
04/07/21 Raymond James
Vroom initiated with an Outperform at Raymond James
03/04/21 Truist
Vroom price target lowered to $54 from $58 at Truist
VRM Vroom
$35.40 /

-1.44 (-3.91%)

  • 07
    Dec
  • 11
    Sep
  • 09
    Jun
VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

Earnings
ContextLogic reports Q1 revenue $772M, consensus $743.09M » 16:11
05/12/21
05/12
16:11
05/12/21
16:11
WISH

ContextLogic

$11.46 /

-0.28 (-2.39%)

Reports Q1 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WISH ContextLogic
$11.46 /

-0.28 (-2.39%)

WISH ContextLogic
$11.46 /

-0.28 (-2.39%)

04/05/21 Evercore ISI
ContextLogic initiated with an Outperform at Evercore ISI
03/30/21 Loop Capital
ContextLogic to 'lap' easy comparisons in Q1, says Loop Capital
03/18/21 JPMorgan
ContextLogic shares attractive at current levels, says JPMorgan
03/09/21 Stifel
ContextLogic price target lowered to $20 from $22 at Stifel
WISH ContextLogic
$11.46 /

-0.28 (-2.39%)

  • 16
    Dec
WISH ContextLogic
$11.46 /

-0.28 (-2.39%)

WISH ContextLogic
$11.46 /

-0.28 (-2.39%)

WISH ContextLogic
$11.46 /

-0.28 (-2.39%)

Hot Stocks
Vroom reports Q1 ecommerce units sold of 15,504, up 96% y/y » 16:10
05/12/21
05/12
16:10
05/12/21
16:10
VRM

Vroom

$35.39 /

-1.45 (-3.94%)

Paul Hennessy, CEO of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$35.39 /

-1.45 (-3.94%)

VRM Vroom
$35.39 /

-1.45 (-3.94%)

04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
04/07/21 Raymond James
Raymond James starts Vroom at Outperform on digital auto secular growth
04/07/21 Raymond James
Vroom initiated with an Outperform at Raymond James
03/04/21 Truist
Vroom price target lowered to $54 from $58 at Truist
VRM Vroom
$35.39 /

-1.45 (-3.94%)

  • 07
    Dec
  • 11
    Sep
  • 09
    Jun
VRM Vroom
$35.39 /

-1.45 (-3.94%)

VRM Vroom
$35.39 /

-1.45 (-3.94%)

VRM Vroom
$35.39 /

-1.45 (-3.94%)

Earnings
NV5 Global reports Q1 adjusted EPS 88c, consensus 84c » 16:10
05/12/21
05/12
16:10
05/12/21
16:10
NVEE

NV5 Global

$81.45 /

-4.55 (-5.29%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVEE NV5 Global
$81.45 /

-4.55 (-5.29%)

NVEE NV5 Global
$81.45 /

-4.55 (-5.29%)

03/29/21 Roth Capital
Roth Capital positive on NV5 acquisition of Geodynamics
03/15/21 Baird
NV5 Global initiated with an Outperform at Baird
01/13/21 Roth Capital
NV5 Global price target raised to $136 from $82 at Roth Capital
11/12/20 Roth Capital
NV5 Global price target raised to $82 from $77 at Roth Capital
NVEE NV5 Global
$81.45 /

-4.55 (-5.29%)

  • 11
    Mar
NVEE NV5 Global
$81.45 /

-4.55 (-5.29%)

Earnings
Vroom reports Q1 EPS (57c), consensus (63c) » 16:09
05/12/21
05/12
16:09
05/12/21
16:09
VRM

Vroom

$35.40 /

-1.44 (-3.91%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
04/07/21 Raymond James
Raymond James starts Vroom at Outperform on digital auto secular growth
04/07/21 Raymond James
Vroom initiated with an Outperform at Raymond James
03/04/21 Truist
Vroom price target lowered to $54 from $58 at Truist
VRM Vroom
$35.40 /

-1.44 (-3.91%)

  • 07
    Dec
  • 11
    Sep
  • 09
    Jun
VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

Earnings
Sonos raises FY21 revenue view to $1.625B-$1.675B from $1.525B-$1.575B » 16:09
05/12/21
05/12
16:09
05/12/21
16:09
SONO

Sonos

$31.63 /

-3.255 (-9.33%)

Consensus $1.56B. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SONO Sonos
$31.63 /

-3.255 (-9.33%)

SONO Sonos
$31.63 /

-3.255 (-9.33%)

03/10/21 Stifel
Sonos price target raised to $40 from $34 at Stifel
03/05/21 Morgan Stanley
Sonos analyst day to be positive catalyst for shares, says Morgan Stanley
02/11/21 Goldman Sachs
Sonos upgraded to Neutral from Sell at Goldman Sachs
02/11/21 Morgan Stanley
Sonos price target raised to $45 from $35 at Morgan Stanley
SONO Sonos
$31.63 /

-3.255 (-9.33%)

  • 18
    Jun
SONO Sonos
$31.63 /

-3.255 (-9.33%)

SONO Sonos
$31.63 /

-3.255 (-9.33%)

SONO Sonos
$31.63 /

-3.255 (-9.33%)

Earnings
Sonos raises FY21 revenue view to $1.625B-$1.675B from $1.525B-$1.575B » 16:09
05/12/21
05/12
16:09
05/12/21
16:09
SONO

Sonos

$31.63 /

-3.255 (-9.33%)

Consensus $1.56B. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SONO Sonos
$31.63 /

-3.255 (-9.33%)

SONO Sonos
$31.63 /

-3.255 (-9.33%)

03/10/21 Stifel
Sonos price target raised to $40 from $34 at Stifel
03/05/21 Morgan Stanley
Sonos analyst day to be positive catalyst for shares, says Morgan Stanley
02/11/21 Goldman Sachs
Sonos upgraded to Neutral from Sell at Goldman Sachs
02/11/21 Morgan Stanley
Sonos price target raised to $45 from $35 at Morgan Stanley
SONO Sonos
$31.63 /

-3.255 (-9.33%)

  • 18
    Jun
SONO Sonos
$31.63 /

-3.255 (-9.33%)

SONO Sonos
$31.63 /

-3.255 (-9.33%)

SONO Sonos
$31.63 /

-3.255 (-9.33%)

Earnings
Avidity Biosciences reports Q1 EPS (64c), consensus (56c) » 16:09
05/12/21
05/12
16:09
05/12/21
16:09
RNA

Avidity Biosciences

$23.18 /

+0.73 (+3.25%)

Reports Q1 revenue $2.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RNA Avidity Biosciences
$23.18 /

+0.73 (+3.25%)

RNA Avidity Biosciences
$23.18 /

+0.73 (+3.25%)

04/26/21 Credit Suisse
Avidity Biosciences assumed with an Outperform at Credit Suisse
07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 SVB Leerink
Avidity Biosciences initiated with an Outperform at SVB Leerink
07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
RNA Avidity Biosciences
$23.18 /

+0.73 (+3.25%)

  • 12
    Jun
Earnings
Strata Skin Sciences reports Q1 EPS (7c), consensus (4c) » 16:08
05/12/21
05/12
16:08
05/12/21
16:08
SSKN

Strata Skin Sciences

$1.51 /

+0.01 (+0.67%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSKN Strata Skin Sciences
$1.51 /

+0.01 (+0.67%)

SSKN Strata Skin Sciences
$1.51 /

+0.01 (+0.67%)

11/03/20
Fly Intel: Top five analyst upgrades
11/03/20 H.C. Wainwright
Strata Skin Sciences upgraded to Buy from Neutral at H.C. Wainwright
SSKN Strata Skin Sciences
$1.51 /

+0.01 (+0.67%)

Earnings
Sonos reports Q2 adjusted EPS 31c, consensus (22c) » 16:08
05/12/21
05/12
16:08
05/12/21
16:08
SONO

Sonos

$31.66 /

-3.22 (-9.23%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SONO Sonos
$31.66 /

-3.22 (-9.23%)

SONO Sonos
$31.66 /

-3.22 (-9.23%)

03/10/21 Stifel
Sonos price target raised to $40 from $34 at Stifel
03/05/21 Morgan Stanley
Sonos analyst day to be positive catalyst for shares, says Morgan Stanley
02/11/21 Goldman Sachs
Sonos upgraded to Neutral from Sell at Goldman Sachs
02/11/21 Morgan Stanley
Sonos price target raised to $45 from $35 at Morgan Stanley
SONO Sonos
$31.66 /

-3.22 (-9.23%)

  • 18
    Jun
SONO Sonos
$31.66 /

-3.22 (-9.23%)

SONO Sonos
$31.66 /

-3.22 (-9.23%)

SONO Sonos
$31.66 /

-3.22 (-9.23%)

Earnings
Biocept reports Q1 EPS 19c vs. ($1.06) a year ago. » 16:08
05/12/21
05/12
16:08
05/12/21
16:08
BIOC

Biocept

$4.75 /

+0.1 (+2.15%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIOC Biocept
$4.75 /

+0.1 (+2.15%)

BIOC Biocept
$4.75 /

+0.1 (+2.15%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
05/14/20 Brookline
Biocept initiated with a Buy at Brookline
BIOC Biocept
$4.75 /

+0.1 (+2.15%)

BIOC Biocept
$4.75 /

+0.1 (+2.15%)

BIOC Biocept
$4.75 /

+0.1 (+2.15%)

Earnings
Flexion reports Q1 EPS (57c), consensus (52c) » 16:08
05/12/21
05/12
16:08
05/12/21
16:08
FLXN

Flexion

$7.50 /

+0.24 (+3.31%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLXN Flexion
$7.50 /

+0.24 (+3.31%)

FLXN Flexion
$7.50 /

+0.24 (+3.31%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
FLXN Flexion
$7.50 /

+0.24 (+3.31%)

  • 21
    May
FLXN Flexion
$7.50 /

+0.24 (+3.31%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.